These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

277 related articles for article (PubMed ID: 15734857)

  • 1. Impaired retinal angiogenesis in diabetes: role of advanced glycation end products and galectin-3.
    Stitt AW; McGoldrick C; Rice-McCaldin A; McCance DR; Glenn JV; Hsu DK; Liu FT; Thorpe SR; Gardiner TA
    Diabetes; 2005 Mar; 54(3):785-94. PubMed ID: 15734857
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Inhibition of advanced glycation and absence of galectin-3 prevent blood-retinal barrier dysfunction during short-term diabetes.
    Canning P; Glenn JV; Hsu DK; Liu FT; Gardiner TA; Stitt AW
    Exp Diabetes Res; 2007; 2007():51837. PubMed ID: 17641742
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Receptor for advanced glycation end products is involved in impaired angiogenic response in diabetes.
    Shoji T; Koyama H; Morioka T; Tanaka S; Kizu A; Motoyama K; Mori K; Fukumoto S; Shioi A; Shimogaito N; Takeuchi M; Yamamoto Y; Yonekura H; Yamamoto H; Nishizawa Y
    Diabetes; 2006 Aug; 55(8):2245-55. PubMed ID: 16873687
    [TBL] [Abstract][Full Text] [Related]  

  • 4.
    López-Díez R; Shen X; Daffu G; Khursheed M; Hu J; Song F; Rosario R; Xu Y; Li Q; Xi X; Zou YS; Li H; Schmidt AM; Yan SF
    Arterioscler Thromb Vasc Biol; 2017 Aug; 37(8):1536-1547. PubMed ID: 28642238
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Upregulation of retinal vascular endothelial growth factor mRNAs in spontaneously diabetic rats without ophthalmoscopic retinopathy. A possible participation of advanced glycation end products in the development of the early phase of diabetic retinopathy.
    Segawa Y; Shirao Y; Yamagishi S; Higashide T; Kobayashi M; Katsuno K; Iyobe A; Harada H; Sato F; Miyata H; Asai H; Nishimura A; Takahira M; Souno T; Segawa Y; Maeda K; Shima K; Mizuno A; Yamamoto H; Kawasaki K
    Ophthalmic Res; 1998; 30(6):333-9. PubMed ID: 9731114
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Cell biology of intraocular vascular diseases].
    Ishibashi T
    Nippon Ganka Gakkai Zasshi; 1999 Dec; 103(12):923-47. PubMed ID: 10643294
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Retinopathy is reduced during experimental diabetes in a mouse model of outer retinal degeneration.
    de Gooyer TE; Stevenson KA; Humphries P; Simpson DA; Gardiner TA; Stitt AW
    Invest Ophthalmol Vis Sci; 2006 Dec; 47(12):5561-8. PubMed ID: 17122149
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Inhibition of diabetic leukostasis and blood-retinal barrier breakdown with a soluble form of a receptor for advanced glycation end products.
    Kaji Y; Usui T; Ishida S; Yamashiro K; Moore TC; Moore J; Yamamoto Y; Yamamoto H; Adamis AP
    Invest Ophthalmol Vis Sci; 2007 Feb; 48(2):858-65. PubMed ID: 17251488
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Advanced glycation end products induce immature angiogenesis in in vivo and ex vivo mouse models.
    Chen L; Cui Y; Li B; Weng J; Wang W; Zhang S; Huang X; Guo X; Huang Q
    Am J Physiol Heart Circ Physiol; 2020 Mar; 318(3):H519-H533. PubMed ID: 31922896
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Catalpol Prevents Glomerular Angiogenesis Induced by Advanced Glycation End Products via Inhibiting Galectin-3.
    Sun WX; Gao YY; Cao Y; Lu JF; Lv GH; Xu HQ
    Curr Med Sci; 2023 Aug; 43(4):668-678. PubMed ID: 37480413
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Chrysin Ameliorates Malfunction of Retinoid Visual Cycle through Blocking Activation of AGE-RAGE-ER Stress in Glucose-Stimulated Retinal Pigment Epithelial Cells and Diabetic Eyes.
    Kang MK; Lee EJ; Kim YH; Kim DY; Oh H; Kim SI; Kang YH
    Nutrients; 2018 Aug; 10(8):. PubMed ID: 30096827
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Advanced glycation endproducts link inflammatory cues to upregulation of galectin-1 in diabetic retinopathy.
    Kanda A; Dong Y; Noda K; Saito W; Ishida S
    Sci Rep; 2017 Nov; 7(1):16168. PubMed ID: 29170525
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The role of advanced glycation end products in retinal microvascular leukostasis.
    Moore TC; Moore JE; Kaji Y; Frizzell N; Usui T; Poulaki V; Campbell IL; Stitt AW; Gardiner TA; Archer DB; Adamis AP
    Invest Ophthalmol Vis Sci; 2003 Oct; 44(10):4457-64. PubMed ID: 14507893
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Involvement of Advanced Glycation End Products in the Pathogenesis of Diabetic Retinopathy.
    Xu J; Chen LJ; Yu J; Wang HJ; Zhang F; Liu Q; Wu J
    Cell Physiol Biochem; 2018; 48(2):705-717. PubMed ID: 30025404
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Growth modulation of retinal microvascular cells by early and advanced glycation products.
    Ruggiero-Lopez D; Rellier N; Lecomte M; Lagarde M; Wiernsperger N
    Diabetes Res Clin Pract; 1997 Jan; 34(3):135-42. PubMed ID: 9069564
    [TBL] [Abstract][Full Text] [Related]  

  • 16. A quick, simple method for detecting circulating fluorescent advanced glycation end-products: Correlation with in vitro and in vivo non-enzymatic glycation.
    Villa M; Parravano M; Micheli A; Gaddini L; Matteucci A; Mallozzi C; Facchiano F; Malchiodi-Albedi F; Pricci F
    Metabolism; 2017 Jun; 71():64-69. PubMed ID: 28521879
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Immunolocalization and quantification of advanced glycation end products in retinal neovascular membranes and serum: a possible role in ocular neovascularization.
    Swamy-Mruthinti S; Miriam KC; Kumar SK; Biswas J; Ramakrishnan S; Nagaraj RH; Sulochana KN
    Curr Eye Res; 2002 Sep; 25(3):139-45. PubMed ID: 12607183
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Blockade by phosphorothioate aptamers of advanced glycation end products-induced damage in cultured pericytes and endothelial cells.
    Higashimoto Y; Matsui T; Nishino Y; Taira J; Inoue H; Takeuchi M; Yamagishi S
    Microvasc Res; 2013 Nov; 90():64-70. PubMed ID: 24012635
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Advanced glycation end products (AGEs) co-localize with AGE receptors in the retinal vasculature of diabetic and of AGE-infused rats.
    Stitt AW; Li YM; Gardiner TA; Bucala R; Archer DB; Vlassara H
    Am J Pathol; 1997 Feb; 150(2):523-31. PubMed ID: 9033268
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Galectin-3/AGE-receptor 3 knockout mice show accelerated AGE-induced glomerular injury: evidence for a protective role of galectin-3 as an AGE receptor.
    Iacobini C; Menini S; Oddi G; Ricci C; Amadio L; Pricci F; Olivieri A; Sorcini M; Di Mario U; Pesce C; Pugliese G
    FASEB J; 2004 Nov; 18(14):1773-5. PubMed ID: 15361471
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 14.